Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Journal of Clinical Medicine|September 10, 2021
Comparison of Glaucoma-Relevant Transcriptomic Datasets Identifies Novel Drug Targets for Retinal Ganglion Cell NeuroprotectionTim J Enz, James R Tribble, Pete A Williams
Frontiers in Ophthalmology|July 10, 2024
Glial metabolic alterations during glaucoma pathogenesisAnne Rombaut, Rune Brautaset, Pete A Williams, et al.
Molecular Brain|November 22, 2024
Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucomaAnne Rombaut, Rune Brautaset, Pete A Williams, et al.
Brain Research Bulletin|June 22, 2025
Amino acid neurotransmitters in sarcopenia and healthy agingSteffi M Jonk, James R Tribble, Peter Swoboda, et al.
Acta Neuropathologica Communications|March 1, 2024
Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volumeAmin Otmani, Gauti Jóhannesson, Rune Brautaset, et al.
Molecular Brain|May 27, 2020
Ocular hypertension suppresses homeostatic gene expression in optic nerve head microglia of DBA/2 J miceJames R Tribble, Jeffrey M Harder, Pete A Williams, et al.
Acta Neuropathologica Communications|August 23, 2024
Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucomaGloria Cimaglia, James R Tribble, Marcela Votruba, et al.
Translational Vision Science & Technology|January 29, 2021
Retinal Ganglion Cell Degeneration in a Rat Magnetic Bead Model of Ocular Hypertensive GlaucomaJames R Tribble, Amin Otmani, Eirini Kokkali, et al.
The American Journal of Pathology|April 20, 2026
SPP1 is reduced in the human retina and optic nerve during glaucoma pathogenesisAlan Nicol, Emma Lardner, Gustav Stålhammar, et al.
Pageof 9